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Abstract 
Questions within and outside of the pharmacy profession frequently arise about a community pharmacy’s capacity to provide 
patient-care services and maximize contributions to public health. It is surmised that community pharmacy locations must possess 
specific attributes and have identifiable resources within the location to effectively initiate and optimize their capacity to deliver 
patient care services in conjunction with medication distribution and other services. The purpose of this paper is to describe three 
research domains that can help pharmacies make the transition from “traditional” business models to “patient care centered” 
practices: (1) Work System Design, (2) Entrepreneurial Orientation, and (3) Organizational Flexibility. From these research domains, 
we identified 21 Work System Design themes, 4 dimensions of Entrepreneurial Orientation, and 4 types of Organizational Flexibility 
that can be used in combination to assist a practice location in transforming its business model to a “patient care centered” practice. 
The self-assessment tools we described in this paper could help realign an organization’s activities to initiate and optimize capacity 
for patient care.  
 
 
Pharmacist Capacity for Contributions to the U.S. Healthcare 
System 
Transformations in pharmacy education and pharmacist 
residency training have created new competencies which 
translate into pharmacist capacity for taking on expanded 
responsibility for optimizing medication use in the U.S. health 
care system [1]. A segmentation analysis using 2009 data [1] 
showed that while 41% of U.S. pharmacists were devoted 
primarily to medication providing (Medication Providers), 
43% percent of pharmacists contributed significantly to 
patient care service provision (Medication Providers who also 
Provide Patient Care, Patient Care Providers who also Provide 
Medication, and Patient Care Providers). The remaining 16% 
(Other Activity Pharmacists) contributed most of their time to 
business/organization management, research, education, and 
other health-system improvement activities.  
 
The pharmacy profession has been building capacity so that 
pharmacists are ideally suited to serve new roles such as 
being: (1) medication care coordinators for patient-centered 
medical homes [2-3] and primary care teams [4-7], (2) 
members of chronic disease management teams that focus 
on ‘episodes’ of care in which related services are packaged 
together [8-9], and (3) the healthcare professional  
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responsible for ensuring optimal medication therapy 
outcomes through medication therapy management (MTM) 
service provision [10-17]. However, as shifts in professional 
roles occur, resources are need for new service provision as 
well as strategic decisions regarding educational training,  
professional training and redeployment, updates to practice 
acts and regulations, new documentation and billing systems, 
enhanced information exchange, collaborative practice 
models, infrastructure, technology, policy, and new business 
models. Resources are scarce, so an understanding of the 
most appropriate timing for making such changes can lead to 
cost-effective use of limited resources for improving patient 
care [18-20].   
 
Positioning and Integrating Pharmacist Contributions to the 
U.S. Healthcare System 
Based on an analysis of data generated from ‘Medication 
Therapy Management (MTM) Environmental Scans’ 
conducted from 2007 through 2010 and from a ‘Future of 
MTM Roundtable’ conducted in October 2010, Schommer, et 
al. proposed that the MTM concept is becoming more 
developed and some aspects of MTM have become 
established within the organizations that are providing and 
paying for these programs [21]. However, their findings also 
showed that there is a need to better integrate MTM 
between organizations and patients serviced (business-to-
consumer [B2C] relationships), between partnering 
organizations (business-to-business [B2B] relationships), and 
between collaborating practitioners (practitioner-to-
practitioner [P2P] relationships) [22, 23]. The findings Idea Paper  PHARMACY PRACTICE 
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suggested that there is an emergent “channel of distribution” 
for MTM program provision through which information, 
services, and payment are created and exchanged [24, 25]. 
For this new channel of distribution, they proposed that (1) 
organizational relationships and (2) cost efficiencies would be 
important considerations in the near term [21].  
The MTM Environmental Scans showed that the developing 
channel of distribution for MTM can be characterized by 
providers that (1) offer MTM primarily out of professionalism 
and patient care motivations, (2) are building competence 
and capacity for these services, and (3) rely on other 
organizations for marketing MTM and identifying patients. 
However, they have been faced with the challenge of 
establishing widely accepted business models and norms for 
conducting transactions for MTM programs.  
 
The channel also can be characterized by MTM payers that 
(1) pay attention to achieving a return on their investment in 
MTM via cost reduction and/or improved performance, (2) 
adjust cost and performance goals from year-to-year to 
reflect organizational strategies, and (3) implement MTM 
programs with a focus on meeting Medicare Part D 
guidelines, supply/demand considerations, and transaction 
cost factors.  
 
Based on insights from an expert panel that participated in a 
Future of MTM Roundtable [21], the channel of distribution 
for MTM was described as having:  
  a poorly developed concept (MTM) in terms of a 
service offering that fits within currently dominant 
practice models 
  a poor fit between MTM and current pharmacy 
practice acts 
  a need to change the pharmacist’s image and to 
increase awareness of MTM programs among 
patients, payers, and other healthcare providers 
  a need for integrated models in which information 
would be accessible and shared, referrals would be 
made, and transaction costs would be minimized for 
organizations that make up the channel of 
distribution for MTM 
  business models that would create enough volume 
for covering the costs of delivering MTM programs.  
 
These findings reveal that the channel of distribution for 
MTM requires substantial changes in the traditional product-
distribution business-models for pharmacies that serve 
ambulatory patients. In 2008, the American Pharmacists 
Association, National Association of Chain Drug Stores, and 
National Community Pharmacists Association initiated Project 
Destiny [26] and developed an approach for moving 
community pharmacy to a stronger position in the healthcare 
market. Project Destiny looked at rearranging the business 
models for community pharmacies in order to provide patient 
care services.  
 
Project Destiny [26] outlined a model and identified a process 
by which community pharmacy can adapt and transform the 
“traditional” business model to a “patient care centered” 
practice. While several early adopters in the profession have 
successfully modified and adapted their business practices to 
facilitate the delivery of patient care services, the widespread 
implementation and mainstreaming of these services in 
pharmacy practice have yet to be achieved.   
 
Questions within and outside of the pharmacy profession 
frequently arise about a community pharmacy’s capacity to 
provide patient-care services and maximize contributions to 
public health. It is surmised that community pharmacy 
locations must possess specific attributes and have 
identifiable resources within the location to effectively 
initiate and optimize their capacity to deliver patient care 
services in conjunction with medication distribution and 
other services [27-28].  
 
The purpose of this paper is to describe three, business-
focused, research domains that can help pharmacies make 
the transition from “traditional” business models to “patient 
care centered” practices. The three domains are: (1) Work 
System Design, (2) Entrepreneurial Orientation, and (3) 
Organizational Flexibility (see Figure 1).  
 
Work System Design  
Chui and her colleagues [29] uncovered and described 
pharmacy work system characteristics that pharmacists 
identified and changed in order to provide “cognitive 
pharmaceutical services” in community pharmacies located in 
Wisconsin. They applied the Systems Engineering Initiative for 
Patient Safety (SEIPS) model to study pharmacy work systems 
[30]. Their approach was grounded in factors-engineering 
principles and was holistic in nature in that it examined 
various components of work structures, processes, and 
outcomes [29, 30].  Chui and her colleagues identified 21 
themes associated with the SEIPS model components (see 
Table 1). They grouped these themes into five overall 
categories:  (1) Person (four themes), (2) Tasks (four themes), 
(3) Environment (one theme), (4) Tools & Technology (four 
themes), and (5) Organization (eight themes). 
 
Chui, et al. noted that the eight themes related to 
organization were addressed “frequently and by the majority 
of pharmacists” in their study. These eight themes were: (1) 
culture, (2) coordination, (3) communication within the 
pharmacy, (4) leadership, (5) management style, (6) goal Idea Paper  PHARMACY PRACTICE 
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setting, (7) teamwork, and (8) compensation. Chui et al.’s 
work is insightful and reveals an important step in building 
capacity for pharmacist-provided, patient-centered services 
in community pharmacies.  They identified 21 important 
facilitators of change that, as a next step, need to be 
translated into actionable undertakings. However, decision-
makers in community pharmacies might be overwhelmed 
with all of the things that need to be changed in order to 
transition from a traditional model into a new patient-
centered model. Decision-makers are faced with many 
questions such as: How does one start to make such 
transitions? How can a traditional model coexist with a new 
model as the transitions are being made? In what order 
should changes be implemented? Is our organization ready 
for change? The next sections of this paper will describe 
pertinent work conducted in two areas that can help address 
these questions.  
 
One area is based upon research conducted in the United 
States by Doucette and colleagues [31] in which they 
identified organizational factors that influence pharmacy 
practice change. The other area is based upon research 
conducted in Australia by Roberts, Feletto and colleagues [32-
36] in which they used an organizational theory framework 
[37] to provide a greater understanding of change processes 
and their facilitators in community pharmacies. 
 
Entrepreneurial Orientation 
The themes identified by Chui and her colleagues create a 
useful “self-assessment” regarding work system design for 
pharmacies to identify what needs to be changed. 
Complementary to their work, Doucette and colleagues [31] 
revealed an association between practice change and 
entrepreneurial orientation. Dimensions of Entrepreneurial 
Orientation that directly affect change capability include: (1) 
proactiveness, (2) risk taking, (3) autonomy, and (4) work 
ethic. These are summarized in Table 2.  Doucette et al. [31] 
developed measures for each dimension that can be rated on 
a 5-point scale from 1 = strongly disagree through 5 = strongly 
agree, and then summed to provide overall scores. Their 
measurement items also are included in Table 2.  
 
We propose that a pharmacy with a relatively high 
entrepreneurial orientation can identify and react to 
emerging trends and market demands. Also, such pharmacies 
would be able to implement work system design changes in 
efficient and effective ways.  
 
Organizational Flexibility 
Some of the themes identified by Chui and her colleagues 
also resonate well with the results of work conducted in 
Australia by Roberts, Feletto and their colleagues [32-36]. 
They applied Volberda’s “Organizational Flexibility” concept 
[37] which has been defined as “the degree to which an 
organization has a variety of managerial capabilities and the 
speed at which they can be activated, to increase the control 
capacity of management and improve the controllability of 
the organization” *37+. There are two determinants of 
organization flexibility.  The first is managerial capabilities, 
which is defined as the capabilities of all employees and their 
ability of integrate knowledge and learning into the 
organization.  The second determinant is called organizational 
design and is defined as the structure, technology, and 
culture of an organization.   
 
Volberda defined four states of organizational flexibility (see 
Table 3):  steady state, operational flexibility, structural 
flexibility, and strategic flexibility [37]. Through their initial 
research [32,33] , Roberts, Feletto, et al. were able to identify 
the following facilitators of practice change that explained 
almost 50% of total variance in their measures of change: 
relationship with physicians, remuneration, pharmacy layout, 
patient expectations, manpower/staff, 
communication/teamwork, and external support/assistance. 
They applied Volberda’s four organizational flexibilities to 
different business models that Australian pharmacies use [34] 
and identified five key areas in which capacity could be built.  
Those areas are: (1) planning (creating a business plan), (2) 
performance (setting financial goals and allocating 
resources), (3) service awareness by the customers, (4) 
people and processes, and (5) infrastructure [35].  Taken 
together, these results explained almost 50% of total variance 
in their measures of organizational change.   
 
In a follow-up study, they measured organizational flexibility 
and used it to assess the capacity of community pharmacy to 
implement change programs [36].  Although they reported 
that their scale had some psychometric limitations and needs 
further development, their findings were consistent with the 
“organizational flexibility” framework and they took steps 
forward in applying the framework “to understand the 
challenge of service implementation and the related capacity 
and integration issues in community pharmacy” *36+. 
 
We propose that a pharmacy characterized by organizational 
flexibility can be responsive to changes occurring in the 
economic and political environments. Pharmacies that have 
identified “what to change” and exhibit a “readiness for 
change” are better-positioned if they also have a managerial 
style that has a relatively high “responsiveness for change.” 
 
Recommendations  
From our review of the literature, we propose that the 
application of Work System Design, Entrepreneurial Idea Paper  PHARMACY PRACTICE 
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Orientation, and Organizational Flexibility can be helpful for 
building community pharmacy work system capacity for 
Medication Therapy Management (MTM). The work by Chui 
et al. revealed 21 Themes [29] that community pharmacy 
decision-makers can use for conducting a self-assessment of 
Work System Design changes that are needed in order to 
create capacity for patient-care services such as MTM. We 
suspect that most pharmacies will be similar to the ones in 
Chui et al.’s study in that the eight “organization” themes will 
surface frequently for the majority of pharmacies (see Table 
1). This focus on Work System Design can be useful for 
identifying “what to change.” 
 
As a next step, a self-assessment regarding an organization’s 
“readiness for change” could be conducted by using 
Doucette et al.’s *31+ measures for the four dimensions of 
Entrepreneurial Orientation (see Table 2). After this second 
step, a pharmacy not only would have identified “what to 
change” through the Work System Design self-assessment, 
but also learned about their “readiness to change” through 
an Entrepreneurial Orientation self-assessment.  
 
Then, to help complement those self-assessments, the work 
by Feletto et al. revealed four types of Organizational 
Flexibility [34-36] that community pharmacy decision-makers 
can use for conducting a self-assessment of management 
style changes that are needed in order to create capacity for 
patient-care services such as MTM (see Table 3). This step 
would help identify an organization’s “responsiveness for 
change.” 
 
The self-assessments we described in this paper may reveal 
that, while a pharmacy can identify what to change, it may 
not exhibit readiness for change, or it may not have a 
management style that is sufficiently responsive for change. If 
this occurs, there is a need for leadership to effect change. A 
useful series regarding Transitions in Pharmacy Practice was 
published by Holland and Nimmo [38-42] and would have 
useful application in these cases. In this five-part series, 
Holland and Nimmo described their views on: (1) taking 
pharmacy practice beyond the pharmaceutical care 
paradigm, (2) new roles for pharmacy personnel, (3) how to 
effect change in pharmacies, (4) how to help personnel be 
prepared for change, and (5) how to motivate personnel as 
change takes place. Germane to our discussion, Part 3 of their 
series describes effecting change through modifying the 
practice environment, training individuals, and using 
motivational strategies [40]. In Part 4, they describe personal 
and social characteristics of pharmacy practitioners that 
dispose them to reacting a certain way to change and how 
this can be addressed [41]. In Part 5, they describe useful 
motivation strategies that might be needed when pharmacy 
practitioners exhibit the fear of “falling off the tight rope” 
while changes are being made [42]. We propose that the 
application of the Holland-Nimmo Practice Change Model 
would help pharmacies overcome challenges related to 
“readiness for change” and “responsiveness for change.”   
 
In summary, we propose that the 21 Work System Design 
themes, the 4 dimensions of Entrepreneurial Orientation, and 
the 4 types of Organizational Flexibility can be used in 
combination to assist a practice location in transforming its 
business model to a “patient care centered” practice. The 
self-assessment tools we described could help realign an 
organization’s activities to initiate and optimize capacity for 
patient care. When self-assessment reveals challenges 
relating to “readiness for change” and “responsiveness for 
change,” we propose that the Holland-Nimmo Practice 
Change Model would be an excellent resource for 
overcoming these challenges. 
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Table 1 
Work System Design: 21 Themes Identified for Community Pharmacy [ref. 29-30]  
 
Person 
  1.  Pharmacist communication skills 
  2.  Pharmacist time management skills 
  3.  Pharmacist/technician psychological characteristics (situation awareness, perseverance) 
  4.  Pharmacist/technician training (formal and on-the-job) 
 
Tasks 
  1.  Job content (actively delegating and initiating services) 
  2.  Scheduling patients for appointments 
  3.  Challenge and utilization of skills 
  4.  Time pressure and workload 
 
Environment 
  1.  Private consultation room 
 
Tools & Technology 
  1.  Pharmacy dispensing system 
  2.  Non-electronic/paper tools (identifying, tracking, and managing patients) 
  3.  Online documentation and billing tools 
  4.  External communications with payers 
 
Organization 
  1.  Culture 
  2.  Coordination 
  3.  Communication within the pharmacy 
  4.  Leadership 
  5.  Management style 
  6.  Goal setting 
  7.  Teamwork 
  8.  Compensation 
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Table 2 
Dimensions of Entrepreneurial Orientation with Measurement Items [ref. 31] 
 
1.  Proactiveness refers to processes designed to scan and react to the current environment to anticipate future needs. 
Anticipating future needs enables pharmacies to identify needed resources to create the capacity for practice change. 
 
Measurement Items: 
___  Our pharmacy usually takes action in anticipation of future market conditions. 
___  We try to shape our business environment to enhance our presence in the market. 
___   Because market conditions are changing, we continually seek out new opportunities. 
 
2.  Risk Taking is the degree to which an organization is inclined to engage in breakthrough initiatives. When a pharmacy 
expands its focus to include the delivery of pharmacy services, it must allocate valuable resources without a 
guaranteed return on investment. 
 
Measurement Items: 
___  Taking gambles is part of our strategy for success. 
___  We take above-average risks in our business. 
___  Taking chances is an element of our business strategy. 
 
3.  Autonomy refers to employees being responsible for their work as well as evaluating their own performance. It also 
denotes the extent to which management is willing to consider ideas brought forth by employees. Motivated 
employees, working in a culture of open communication, can reduce employee resistance to change, which increases 
an organization’s change capacity. 
 
Measurement Items: 
___  New service ideas suggested by employees are acted upon by decision makers. 
___  Management approves of independent activity by employees to develop new services. 
___  Identifying new business opportunities is the concern of all employees. 
 
 
4.  Work Ethic describes attitudes toward and moral belief in hard work. Highly motivated, hardworking employees can 
facilitate practice change. 
 
Measurement Items: 
___  We consider ourselves as having high motivation toward work. 
___  Our employees are a group of hardworking individuals. 
___  At our pharmacy, we are very ambitious about our work. 
 
  
 
 
 
 
 
 
 
Measurement items for each dimension can be rated on a 5-point scale from 1 = strongly disagree through 5 = strongly agree,                
and then summed to provide overall scores.      
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Table 3 
Four Types of Organizational Flexibility [ref. 32-37] 
 
1.  Steady state is described by constant procedures being used within an environment that is considered to be stable. 
  
2.  Operational flexibility is described by a low variety of capabilities and high responsiveness to market demands. This 
focus means that a firm has a short-term orientation and is trying to respond to predictable changes in the 
environment. 
 
3.  Structural flexibility is described by managerial capabilities that are used to alter a firm’s structure, including decision-
making and communications processes, relative to both internal and external pressures. This focus suggests a medium 
term time orientation.  
 
4.  Strategic flexibility is described by a firm’s ability to engage in proactive strategic initiatives. The focus is on the goals 
and activities being less structured and non-routine in order to accommodate changing conditions. A long-term focus is 
generally used within an environment that is considered to be uncertain. 
 
 
 
 
Figure 1 
Summary of Work System Design, Entrepreneurial Orientation, and Organizational Flexibility 
 
 
 
 
 
 
 
 
     
 
   
 
Work System Design 
(what to change) 
 
Person 
Tasks 
Environment 
    Tools & Technology 
Organization 
Entrepreneurial 
Orientation 
(readiness for change) 
 
Proactiveness 
Risk Taking 
Autonomy 
Work Ethic 
Organizational 
Flexibility 
(responsiveness for change) 
 
Steady State 
Operational Flexibility 
Structural Flexibility 
Strategic Flexibility 